HOME >> MEDICINE >> NEWS
Using MRI for diagnosis could help prevent breast cancer progression

Using magnetic resonance imaging (MRI) to diagnose breast cancer in its intraductal stage could help prevent the development of invasive cancer, conclude authors of an Article in this weeks edition of The Lancet. And an accompanying Comment says that the findings show that MRI should now be used as a distinct method in its own right to detect breast cancer in its earliest stage.

Professor Christiane Kuhl, Department of Radiology, University of Bonn, Germany and colleagues studied 7319 women over a five-year period who had been referred to an academic breast centre. The women received MRI in addition to conventional mammography for diagnostic assessment and screening, with the aim of discovering the sensitivity of each method for diagnosing ductal carcinoma in situ (DCIS). Mammograms and MRI scans were then assessed independently by different radiologists, and the relative sensitivity of each method of detection was assessed by comparing the biological profiles of mammography-detected DCIS with those of MRI-detected DCIS.

The researchers found that of 167 women who had a diagnosis of DCIS, 153 (92%) were diagnosed by MRI compared with 93 (56%) diagnosed by mammography. Whereas the sensitivity of MRI for diagnosing DCIS increased with nuclear grade, that of mammography decreased. Of 89 women diagnosed with high grade DCIS, 87 (98%) were diagnosed by MRI, but only 46 (52%) by mammography. Accordingly, almost half (48%) were missed by mammography but diagnosed by MRI alone. They also found that age, menopausal status, personal or family history of breast cancer, and breast density of women with MRI-only diagnosed disease did not differ significantly from those of women with mammography-diagnosed DCIS. The higher sensitivity of MRI was not associated with an unduly high number of false positive diagnoses - the positive predictive value of both methods was comparable, with 55% for mammography, and 59% for MRI.

The authors conclude: Our s
'"/>

Contact: Professor Christiane Kuhl
kuhl@uni-bonn.de
49-288-287-19875
Lancet
9-Aug-2007


Page: 1 2

Related medicine news :

1. Using coxibs and NSAIDs to treat osteoarthritis
2. Using morphine to hasten death is a myth, says doctor
3. Using nanomagnets to enhance medical imaging
4. Using contrast enhanced sonography improves diagnosis of liver and spleen injuries
5. Using device to give CPR does not improve survival
6. Using HPV testing to screen for cervical cancer
7. Citizen consumers? Using public services is not like shopping
8. Using statins to potentially treat rheumatoid arthritis
9. Using mobile phones reduces error rate in hospital care
10. Medical management of another condition may not lead to early cancer diagnosis
11. TB test offers patients quicker and easier diagnosis

Post Your Comments:
(Date:5/20/2013)... exposure to traffic-related air pollution was significantly associated ... to new research from the University of Cincinnati ... The research is detailed in a study being ... Perspectives , a peer-reviewed open access journal published ... an institute within the National Institutes of Health ...
(Date:5/20/2013)... 2013 For the third consecutive ... of Frederick Award in the Professional Standards Review ... , The USCA "Best of Local Business" Award ... Each year, the USCA identifies companies that they ... local community and business category. These are local ...
(Date:5/20/2013)... May 20, 2013 The new healthcare ... and health of all Americans. However, not all the ... impact as some might take up to 2014 to ... Services (HHS), some states are currently moving forward to ... Marketplaces, such as: Iowa, Michigan, New Hampshire, and West ...
(Date:5/20/2013)... Denver, Colorado (PRWEB) May 20, 2013 Daily ... willing to provide its readers with useful tips that can ... vitiligo. , According to the website Natural Vitiligo ... due to the numerous positive reviews it has received from ... a secret until now, but Daily Gossip has interviewed some ...
(Date:5/20/2013)... Australia (PRWEB) May 21, 2013 People are ... next. Stress levels are through the roof and are ... people handle this stress could mean the difference between life ... Change Begin’ event on 29 May will share valuable, practical ... wellbeing and influence the world around them for social good. ...
Breaking Medicine News(10 mins):Health News:Early-life traffic-related air pollution exposure linked to hyperactivity 2Health News:A2LA Receives 2013 Best of Frederick Award 2Health News:Review of Health Bill Impact in 2014 2Health News:Review of Health Bill Impact in 2014 3Health News:New Natural Vitiligo Treatment System That Helps People Treat Vitiligo Permanently Revealed by Daily Gossip Magazine 2Health News:Chill Out and Change the World, Say Mind Experts at V Star Bliss Event in Sydney 2
(Date:5/20/2013)... CARLSBAD, Calif. , May 20, 2013   ... today announced that its Applied Biosystems™ 3500 Dx and ... Federal Commission for Protection against Health Risks in ... marks a major extension of Life Technologies, capabilities to ... America with Sanger -based ...
(Date:5/20/2013)... May 20, 2013 Enrollment of patients with ... 2b dose-finding clinical trial of product candidate NewMet ... treatment for Type 2 diabetes. Elcelyx expects to complete ... in June. Results of the trial,s primary endpoint of ... summer, and the read-out for long-term glucose lowering and ...
(Date:5/20/2013)... , May 20, 2013  Medicare Part ... are overwhelmingly satisfied, citing lower costs, convenient access ... new survey from Hart Research Associates released today ... than 40% of Part D seniors (9.5 million) ... "Seniors like the lower costs, pharmacy ...
Breaking Medicine Technology:Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 2Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 4Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices 2
Cached News: